| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Feb―15 |
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative |
Raoel Maan, Mandy N. Lauw, Loise China, David Patch, Anna Baiges, Juan Carlos Garcia-Pagan, Virginia Hernández-Gea, Marie-Noelle Hilleret, Eric T. Tjwa, Ilias Kounis, Christophe Bureau, Baptiste Giguet, Alexandra Heurgué, Isabelle Ollivier-Hourmand, Xavier Causse, Filipe Nery, Ahad Eshraghian, Aurélie Plessier, Sarwa Darwish Murad |
| 2 |
[GO] |
2023―Jul―17 |
Letter to the Editor: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection? |
Yue Hu, Zheng Li, Weilan He, Xin Wang, Xinran Cheng |
| 3 |
[GO] |
2023―Jul―17 |
Reply: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection? |
Jin Ge, Jean C. Digitale, Mark J. Pletcher, Jennifer C. Lai |
| 4 |
[GO] |
2023―Apr―10 |
Reply: progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease |
Lukas Hartl, Thomas Reiberger, Michael Trauner |
| 5 |
[GO] |
2023―Apr―10 |
Letter to the editor: progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease |
Sumayya Umar, Arsalan Nadeem, Muntaha Nadeem |
| 6 |
[GO] |
2023―Jan―27 |
The road to pandemic recovery: Tracking COVID-19’s impact on cirrhosis care and outcomes among 111,558 veterans |
Adeyinka C. Adejumo, Vera Yakovchenko, Timothy R. Morgan, Patrick Spoutz, Linda Chia, Jasmohan S. Bajaj, Michael F. Chang, Jason A. Dominitz, Shari S. Rogal |
| 7 |
[GO] |
2022―Sep―10 |
Breakthrough
SARS-CoV
-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A
N3C
Study |
Jin Ge, Jean C. Digitale, Mark J. Pletcher, Jennifer C. Lai, Christopher G. Chute, Jeremy R. Harper, Davera Gabriel, Melissa A. Haendel, Emily Pfaff, Peter Leese |
| 8 |
[GO] |
2022―Sep―06 |
Postvaccination COVID-19 related mortality in patients with cirrhosis:who is the culprit? |
Zhihui Duan |
| 9 |
[GO] |
2022―Aug―24 |
COVID-19 related mortality in Cirrhosis is not associated with Proton Pump Inhibitor Exposure |
Binu V. John, Bassam Dahman |
| 10 |
[GO] |
2022―Aug―24 |
COVID-19 Vaccination and mortality in Decompensated Cirrhosis |
Binu V. John, Bassam Dahman |
| 11 |
[GO] |
2022―Aug―24 |
Could COVID-19 vaccination reduce post-infection mortality in most cirrhotic patients ? |
Gin-Ho Lo |
| 12 |
[GO] |
2022―Jul―12 |
Letter to the Editor: Complications following SARS-CoV-2 infection in patients with chronic liver disease |
Shi-Tao Jiang, Lei Zhang, Yi-Yao Xu, Xin Lu |
| 13 |
[GO] |
2022―Jun―17 |
Comparison of Infection-induced and Vaccine-induced Immunity Against Coronavirus 2019 in Patients with Cirrhosis |
Binu V. John, Akash Doshi, Raphaella D. Ferreira, Tamar H. Taddei, David E. Kaplan, Seth A. Spector, Yangyang Deng, Dustin Bastaich, Bassam Dahman |
| 14 |
[GO] |
2022―May―14 |
Liver injury after
SARS-CoV
-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome |
Cumali Efe, Anand V. Kulkarni, Benedetta Terziroli Beretta-Piccoli, Bianca Magro, Albert Friedrich Stättermayer, Mustafa Cengiz, Daniel Clayton-Chubb, Craig Lammert, Christine Bernsmeier, Özlem Gül, Fatima Higuera-de Tijera, Margarita Anders, Ellina Lytvyak, Mete Akın, Tugrul Purnak, Rodrigo Liberal, Mirta Peralta, Berat Ebik, Serkan Duman, Nurhan Demir, Yasemin Balaban, Álvaro Urzua, Fernando Contreras, Maria Grazia Venturelli, Yılmaz Bilgiç, Adriana Medina, Marcos Girala, Fulya Günşar, Maria-Carlota Londoño, Theodoros Androutsakos, Ayelen Kisch, Alper Yurci, Fatih Güzelbult, Yasir Furkan Çağın, Enver Avcı, Murat Akyıldız, Emine Kübra Dindar-Demiray, Murat Harputluoğlu, Rahul Kumar, Sanjaya K. Satapathy, Manuel Mendizabal, Marcelo Silva, Stefano Fagiuoli, Stuart K. Roberts, Neşe Karadağ Soylu, Ramazan Idilman, Eric M. Yoshida, Aldo J. Montano-Loza, George N. Dalekos, Ezequiel Ridruejo, Thomas D. Schiano, Staffan Wahlin |
| 15 |
[GO] |
2022―Apr―05 |
Letter to the editor: Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study |
Ahmad hayat |
| 16 |
[GO] |
2022―Feb―17 |
Liver transplantation following SARS-CoV-2 vaccination-induced liver failure |
Cumali Efe, Murat Harputluoğlu, Neşe Karadağ Soylu, Sezai Yilmaz |
| 17 |
[GO] |
2022―Jan―13 |
Post-Vaccination COVID-19 Infection is Associated with Reduced Mortality in Patients With Cirrhosis |
Binu V. John, Yangyang Deng, Kaley B Schwartz, Tamar H. Taddei, David E. Kaplan, Paul Martin, Hann-Hsiang Chao, Bassam Dahman |
| 18 |
[GO] |
2021―Dec―14 |
Letter to the Editor: Autoimmune hepatitis after COVID-19 vaccination: Need for population based-epidemiological study |
Yuji Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa |
| 19 |
[GO] |
2021―Dec―09 |
Reactivation of Hepatitis B virus triggered by SARS-COV2 in a cirrhotic patient |
Marta Librero Jiménez, María Ángeles López Garrido, María Carmen Fernández Cano |
| 20 |
[GO] |
2021―Dec―08 |
Effect of Increased Alcohol Consumption During COVID-19 Pandemic on Alcohol-related Liver Disease: A Modeling Study |
Jovan Julien, Turgay Ayer, Elliot B Tapper, Carolina Barbosa, William Dowd, Jagpreet Chhatwal |
| 21 |
[GO] |
2021―Dec―04 |
Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination |
Zhujun Cao, Honglian Gui, Zike Sheng, Haiguang Xin, Qing Xie |
| 22 |
[GO] |
2021―Nov―19 |
Lettter to the editor on “Autoimmune hepatitis after COVID-19 vaccination” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 23 |
[GO] |
2021―Sep―16 |
Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination. A rare adverse effect? |
Panagiota Palla, Chrysovalantis Vergadis, Stratigoula Sakellariou, Theodoros Androutsakos |
| 24 |
[GO] |
2021―Aug―15 |
Reply to Letters to the Editor: Clinical outcomes in COVID-19 patients with current or past hepatitis B virus infection |
Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong |
| 25 |
[GO] |
2021―Aug―13 |
Outcomes in chronic hepatitis B infection and COVID-19 - Not always benign ! |
Ankur Jindal |
| 26 |
[GO] |
2021―Aug―13 |
Letter to the Editor: unanswered questions about hepatitis B virus infection in patients with COVID-19 |
Xiu-He Lv, Jin-Lin Yang, Kai Deng |
| 27 |
[GO] |
2021―Jul―26 |
Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States |
George Cholankeril, Karthik Goli, Abbas Rana, Ruben Hernaez, Alexander Podboy, Prasun Jalal, Ben L. Da, Sanjaya K. Satapathy, Donghee Kim, Aijaz Ahmed, John Goss, Fasiha Kanwal |
| 28 |
[GO] |
2021―May―09 |
Current and past infections of hepatitis B virus do not increase mortality in patients with COVID-19 |
Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Chung-Yan Lui, Viola Chi-Ying Chow, Yee-Kit Tse, Vicki Wing-Ki Hui, Lilian Yan Liang, Henry Lik-Yuen Chan, David Shu-Cheong Hui, Grace Lai-Hung Wong |
| 29 |
[GO] |
2021―Apr―29 |
Letter to the Editor: Liver Biochemistries in Hospitalized Chinese Patients With Severe Coronavirus Disease 2019 |
Ya Gao, Ming Liu, Shuzhen Shi, Jinhui Tian |
| 30 |
[GO] |
2021―Mar―13 |
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study |
Cumali Efe, Renumathy Dhanasekaran, Craig Lammert, Berat Ebik, Fatima Higuera-de la Tijera, Costica Aloman, Ali Rıza Calışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M. Catana, Murat Torgutalp, Tugrul Purnak, Cristina Rigamonti, Andres Jose Gomez Aldana, Nidah Khakoo, Hüseyin Kacmaz, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader Irak, Zeynep Melekoğlu Ellik, Yasemin Balaban, Kadri Atay, Fatih Eren, Laura Cristoferi, Ersin Batıbay, Álvaro Urzua, Romee Snijders, Murat Kıyıcı, Murat Akyıldız, Nazım Ekin, Rotonya M. Carr, Murat Harputluoğlu, Ibrahim Hatemi, Manuel Mendizabal, Marcelo Silva, Ramazan Idilman, Marina Silveira, Joost P.H. Drenth, David N. Assis, Einar Björnsson, James L. Boyer, Pietro Invernizzi, Chyntia Levy, Thomas D. Schiano, Ezequiel Ridruejo, Staffan Wahlin |
| 31 |
[GO] |
2021―Mar―05 |
Letter to the Editor: Serum Albumin in COVID-19: A Good Example in Which Analytical and Clinical Performance of a Laboratory Test Are Strictly Intertwined |
Sara Pasqualetti, Elena Aloisio, Mauro Panteghini |
| 32 |
[GO] |
2021―Feb―14 |
AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease |
Oren K. Fix, Emily A. Blumberg, Kyong-Mi Chang, Jaime Chu, Raymond T. Chung, Elizabeth K. Goacher, Bilal Hameed, Daniel R. Kaul, Laura M. Kulik, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Jennifer C. Price, Nancy S. Reau, K. Rajender Reddy, Andrew Reynolds, Hugo R. Rosen, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Verna, John W. Ward, Robert J. Fontana |
| 33 |
[GO] |
2021―Feb―03 |
Covid-19 and liver cirrhosis: focus on the non-classical renin-angiotensin system and implications for therapy |
Giovanni Sansoè, Manuela Aragno, Florence Wong |
| 34 |
[GO] |
2020―Dec―18 |
Liver disease and COVID-19: from Pathogenesis to Clinical Care |
Antonio Saviano, Florian Wrensch, Marc G. Ghany, Thomas F. Baumert |
| 35 |
[GO] |
2020―Nov―24 |
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient with COVID-19 |
Sally A.I. Knooihuizen, Ariel Aday, William M. Lee |
| 36 |
[GO] |
2020―Nov―21 |
Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality. |
George N. Ioannou, Peter S. Liang, Emily Locke, Pamela Green, Kristin Berry, Ann M. O’Hare, Javeed A. Shah, Kristina Crothers, McKenna C. Eastment, Vincent S Fan, Jason A. Dominitz |
| 37 |
[GO] |
2020―Nov―14 |
Letter to the Editors: More Efforts for Detecting the Elevated Liver Biochemistries in Patients with Severe COVID-19 |
Yi-Ming Lin, Ai-Yong Cui, Da-Wei Wang, Hua-Ding Lu |
| 38 |
[GO] |
2020―Nov―05 |
Addressing Social Determinants of Liver Disease during the COVID-19 Pandemic and Beyond: A Call to Action |
Ani Kardashian, Julius Wilder, Norah A. Terrault, Jennifer C. Price |
| 39 |
[GO] |
2020―Sep―27 |
Reply to Letter to the Editor: Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-Analysis |
Alexander J. Kovalic, Glen Huang, Paul J. Thuluvath, Sanjaya K. Satapathy |
| 40 |
[GO] |
2020―Sep―23 |
Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience |
Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Ponni Perumalswami, Veronica Nguyen, Akshata Moghe, Nyann Latt, Sonal Kumar, Costica Aloman, Andreea M. Catana, Patricia P. Bloom, Kenneth Chavin, Rotonya M. Carr, Winston Dunn, Vincent Chen, Elizabeth S. Aby, Jose Debes, Renumathy Dhanasekaran, Donghee Kim, Marina Roytman, Kathleen Viveiros, Walter Chan, Michael Li, Alexander Vogel, Kara Wegerman, Tzu-Hao Lee, Kali Zhou |
| 41 |
[GO] |
2020―Aug―15 |
Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic |
Naim Alkhouri, Anita Kohli, Rohit Loomba, Stephen A. Harrison |
| 42 |
[GO] |
2020―Aug―08 |
Letter to the Editors: COVID-19-Related Liver Injury: The Interpretation for Aspartate Aminotransferase Needs to Be Cautious |
Xiu-He Lv, Jin-Lin Yang, Kai Deng |
| 43 |
[GO] |
2020―Aug―08 |
Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven |
Lucy Meunier, Magdalena Meszaros, Georges-Philippe Pageaux |
| 44 |
[GO] |
2020―Aug―02 |
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation |
Elizabeth C. Verna, Marina Serper, Jaime Chu, Kathleen Corey, Oren K. Fix, Karen Hoyt, Kimberly A. Page, Rohit Loomba, Ming Li, Gregory T. Everson, Michael W. Fried, Guadalupe Garcia-Tsao, Norah Terrault, Anna S. Lok, Raymond T. Chung, K. Rajender Reddy |
| 45 |
[GO] |
2020―Jul―29 |
Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network |
Melanie A. Hundt, Yanhong Deng, Maria M. Ciarleglio, Michael H. Nathanson, Joseph K. Lim |
| 46 |
[GO] |
2020―Jul―23 |
Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis |
Anna Bertolini, Ivo P. van de Peppel, Frank A.J.A. Bodewes, Han Moshage, Alberto Fantin, Fabio Farinati, Romina Fiorotto, Johan W. Jonker, Mario Strazzabosco, Henkjan J. Verkade, Giulia Peserico |
| 47 |
[GO] |
2020―Jul―21 |
Elevated Liver Biochemistries in Hospitalized Chinese Patients with Severe COVID-19: Systematic Review and Meta-analysis |
Alexander J. Kovalic, Glen Huang, Paul J. Thuluvath, Sanjaya K. Satapathy |
| 48 |
[GO] |
2020―Jul―12 |
“Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient” |
Thomas Reiberger, Mattias Mandorfer |
| 49 |
[GO] |
2020―Jul―03 |
Letter to the Editors: Additional Factors to Consider When Studying Liver Injury Indicators and Mortality in COVID-19 Patients |
Yanqing Liu |
| 50 |
[GO] |
2020―Jul―03 |
Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist? |
Cyriac Abby Philips, Rizwan Ahamed, Philip Augustine |
| 51 |
[GO] |
2020―Jul―02 |
Reply to Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist? |
Fang Lei, Ye-Mao Liu, Feng Zhou, Juan-Juan Qin, Xiaodong Huang, Bing-Hong Zhang, Hongliang Li, Yufeng Yuan |
| 52 |
[GO] |
2020―Jun―30 |
Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study |
Yu Fu, Rui Zhu, Tao Bai, Ping Han, Qin He, Mengjia Jing, Xiaofeng Xiong, Xi Zhao, Runze Quan, Chaoyue Chen, Ying Zhang, Meihui Tao, Jianhua Yi, Dean Tian, Wei Yan |
| 53 |
[GO] |
2020―May―30 |
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort |
Meaghan M. Phipps, Luis H. Barraza, Elijah D. LaSota, Magdalena E. Sobieszczyk, Marcus R. Pereira, Elizabeth X. Zheng, Alyson N. Fox, Jason Zucker, Elizabeth C. Verna |
| 54 |
[GO] |
2020―May―16 |
Liver Biochemistries in Hospitalized Patients With COVID-19 |
Patricia P. Bloom, Eric A. Meyerowitz, Zoe Reinus, Michael Daidone, Jenna Gustafson, Arthur Y. Kim, Esperance Schaefer, Raymond T. Chung |
| 55 |
[GO] |
2020―May―05 |
COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease |
Ben L. Da, Gene Y. Im, Thomas D. Schiano |
| 56 |
[GO] |
2020―Apr―16 |
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement |
Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Daniel S. Pratt, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Verna, Rohit Loomba, David E. Cohen, Jorge A. Bezerra, K. Rajender Reddy, Raymond T. Chung |
| 57 |
[GO] |
2020―Apr―10 |
Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action? |
Marina Serper, Allen W. Cubell, Mary Elisabeth Deleener, Tara K. Casher, Dale J. Rosenberg, Dale Whitebloom, Roy M. Rosin |
| 58 |
[GO] |
2020―Mar―27 |
Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient |
Juanjuan Qin, Haitao Wang, Xuan Qin, Peng Zhang, Lihua Zhu, Jingjing Cai, Yufeng Yuan, Hongliang Li |
|
